Blood Transfusion Diagnostics Market Anticipated to Reach USD 8.44 Billion by 2034, Growing at a CAGR of 5.00%
The global Blood Transfusion Diagnostics Market was valued at USD 4.91 billion in 2024, and it is projected to grow to USD 8.44 billion by 2034. During the forecast period from 2025-2034, the market is estimated to rise at a compound annual growth rate (CAGR) of 5.00%. This upward trajectory is largely fueled by the need for safe blood screening and technological advancements in diagnostic assays.
Market Definition
The Blood Transfusion Diagnostics market is expanding due to rising demand for safe transfusions, growing prevalence of blood disorders, advancements in screening technologies, and increased awareness of transfusion-transmitted infections.
Key Report Highlights
· The report highlights the key region that accounts for the highest revenue share in the global Blood Transfusion Diagnostics market.
· It identifies the leading country within this region that makes a significant contribution to the market’s overall performance.
· The report outlines the dominant segment that holds a major share of the market.
· It also emphasizes the fastest-growing segment projected to gain strong traction during the forecast period.
· Qualitative and quantitative market analysis have been used to provide an in-depth understanding of the market.
Market Overview: Key Figures at a Glance
· Market Value in 2024: USD 4.91 billion
· Projected Market Size in 2034: USD 8.44 billion
· Anticipated CAGR (2025-2034): 5.00%
Get access to the full report or request a complimentary sample for in-depth analysis:
Market Key Players
The competitive landscape features a mix of long-standing companies and emerging contenders. Leading players are actively pursuing R&D initiatives and strategic moves to strengthen their market position. Notable participants include
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Diamond Diagnostics
- Diagnostica Stago
- Electro Medical Technologies
- F. Hoffmann-La Roche Ltd
- Grifols S.A.
- Immucor Inc.
- Ortho Clinical Diagnostics
- Quotient Ltd.
Blood Transfusion Diagnostics Market – Growth Drivers:
- Rising Demand for Safe Blood Transfusions: Increasing awareness and need for accurate screening to prevent transfusion-transmitted infections drive market growth.
- Growing Prevalence of Chronic and Infectious Diseases: Higher rates of conditions like cancer, anemia, and hemophilia increase the need for frequent blood transfusions and related diagnostics.
- Advancements in Diagnostic Technologies: Innovations in molecular testing, nucleic acid testing, and automation improve the accuracy and efficiency of transfusion diagnostics.
- Expansion of Healthcare Infrastructure: Growth in healthcare facilities and blood banks, especially in emerging economies, boosts the demand for transfusion diagnostic solutions.
